The Director, Medicinal Chemistry is responsible for co-leading a full-phase small molecule antiviral discovery program from lead optimization through candidate nomination, and for contributing design ideas and scientific judgment across the rest of the medicinal chemistry portfolio. Assembly Biosciences (Nasdaq: ASMB) is a clinical-stage biotechnology company developing small molecule therapeutics for serious viral and liver diseases. Our pipeline spans hepatitis B virus (HBV), hepatitis delta virus (HDV), herpesviruses, and additional antiviral targets, supported by a collaboration with Gilead Sciences. We are a dynamic, science-driven organization where individual scientists have visible and direct impact on company development. The medicinal chemistry group is deliberately small, and each member co-leads at least one full-phase discovery program while also driving early-phase programs. All wet chemistry is executed through our designated CRO partners. Our internal chemists are responsible for MedChem strategy, compound design, and rigorous oversight of external executions to ensure direction, focus, and productivity. The Director will be expected to contribute scientific input to programs beyond his/her own; the ability to work generously and effectively in a team setting is as critical as individual technical excellence.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree